|
Advisory Committees
Nature and Basis Statements of
Conflict(s) of Interest for Voting Members of FDA Advisory Committee
Members
The Agency is revising its
procedures regarding the disclosure of conflicts of interest and
waivers for voting advisory committee members in order to implement
the requirements of section 795 of Pub. L. No. 109-97 (Agriculture,
Rural Development, Food and Drug Administration, and Related
Agencies Appropriations Act, 2006) (Nov. 10, 2005). This information
is being provided as an interim measure to comply with the
requirements of this law.
Meeting of the Drug Safety and Risk Management Advisory Committee
February 9-10, 2006
Elizabeth Andrews, M.P.H., Ph.D. (Added January 30, 2006)
Terry Davis, Ph.D.
Thomas Fleming, Ph.D.
Peter A. Gross, M.D.
Steve Nissen, M.D.
Page updated: February 8, 2006 |
|